MANUFACTURING AND SUPPLY AGREEMENTConfidential Treatment • August 9th, 2005 • Neorx Corp • In vitro & in vivo diagnostic substances • Massachusetts
This Manufacturing and Supply Agreement (“Agreement”) is entered into as of the date signed by the last party to sign this Agreement, and with an effective date of May 4, 2005 (the “Effective Date”) by and between Hyaluron Inc., with its principal place of business at 99 S. Bedford Street, Suite 2, Burlington, MA 01803, (“Hyaluron”) and NeoRx, a Washington corporation, having its principal place of business at 300 Elliott Avenue West, Suite 500, Seattle, Wa 98119-4114. Hyaluron and NeoRx may be referred to herein as a “Party” or, collectively, as the “Parties”.
CONSULTING AGREEMENTConsulting Agreement • August 9th, 2005 • Neorx Corp • In vitro & in vivo diagnostic substances • Washington
THIS CONSULTING AGREEMENT is made between NeoRx Corporation (hereinafter referred to as “NeoRx”), with addresses at 300 Elliott Avenue West, Suite 500, Seattle, Washington 98119, and Alan B. Glassberg, M.D. (hereinafter referred to as “Consultant”), with address at 126 Poplar Drive, Kentfield, California 94904.
